Skip to main content
. 2019 Mar 28;161(5):875–884. doi: 10.1007/s00701-019-03878-5

Table 2.

Patient outcome

Patient category N N (%) death ^ N (%) GOS1–3 N (%) returned QOLIBRI# QOLIBRI score QOLIBRI follow-up (months)
All patients 108 48 (44) 56 (53) 25 (23) 62.8 ± 23.5 37 ± 17
Age ≥ 65 65 21 (32) 29 (45) 16 (25) 66.8 ± 22.1 38 ± 18
Age < 65 43 19 (44) 27 (63) 9 (21) 55.7 ± 25.6 35 ± 16
GCS 3 10 7 (70) 9 (90) 0 N/A N/A
GCS 3–5 22 14 (64) 17 (77) 2 (9) 66.0 ± 7.07 13 ± 2
GCS 3–8 49 30 (61) 35 (71) 7 (14) 61.4 ± 24.8 34 ± 19
GCS 9–12 19 9 (47) 10 (53) 4 (21) 61.0 ± 25.5 50 ± 21
GCS 13–15 40 9 (23) 11 (28) 14 (35) 64.0 ± 24.1 35 ± 14
Pupillary abnormality 27 15 (56) 19 (70) 5 (19) 49.8 ± 19.4 47 ± 23
No abnormalities* 74 29 (39) 32 (43) 18 (24) 64.5 ± 24.6 32 ± 13
Emergency surgery
  No 18 3 (17) 3 (17) 4 (22) 56.3 ± 28.6 33 ± 15
  Craniotomy 60 26 (43) 32 (53) 15 (25) 68.4 ± 21.0 36 ± 17
  Decompressive craniectomy 29 18 (62) 21 (72) 6 (21) 53.2 ± 26.3 42 ± 21
  ICP monitoring 40 20 (50) 30 (75) 9 (23) 55.1 ± 20.4 36 ± 24
  No ICP monitoring 68 28 (41) 26 (38) 16 (24) 67.1 ± 24.7 37 ± 13
Outcome (GOS)
  Favorable 50 4 (8) N/A 23 (46) 63.9 ± 23.3 37 ± 17
  Unfavorable 56 42 (75) 56 (100) 2 (4) 37 ± 25
  Missing 2 50.5 ± 2.1

Table 2 provides an overview of mortality, functional outcome and health related quality of life per subgroup. Legend: results presented as number (row percentage) and mean ± SD

#The response rate is reported as percentage of survivors from the specific category

*Pupillary abnormality information was missing for seven patients

^Mortality at time of QOLIBRI follow-up

LOS, length of stay; GCS, Glasgow Coma Score; ICP, intracranial pressure; QOLIBRI, quality of life after brain injury; M, months; N/A, not applicable